These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 175138)

  • 21. [A comparison of osteotropic radiopharmaceuticals. II. Plasma clearance of 18F and 99mTc-EHDP (author's transl)].
    Creutzig H
    Rofo; 1975 Oct; 123(4):313-8. PubMed ID: 129388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Observations on the mechanism of 99mTc-labeled phosphate complex uptake in metabolic bone disease.
    Rosenthall L; Kaye M
    Semin Nucl Med; 1976 Jan; 6(1):59-67. PubMed ID: 174229
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Technetium-99m-labeled stannous imidodiphosphate, a new radiodiagnostic agent for bone scanning: comparison with other 99mTc complexes.
    Subramanian G; McAfee JG; Blair RJ; Rosenstreich M; Coco M; Duxbury CE
    J Nucl Med; 1975 Dec; 16(12):1137-43. PubMed ID: 1194964
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 99mTc bone scanning agents--II. Adsorption of 99mTc(Sn)pyrophosphate complexes on the mineral phase of bone.
    Kroesbergen J; van Steijn AM; Gelsema WJ; de Ligny CL
    Int J Nucl Med Biol; 1986; 12(6):411-7. PubMed ID: 3011692
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bone kinetics of calcium-45 and pyrophosphate labeled with technetium-96: an autoradiographic evaluation.
    Guillemart A; Le Pape A; Galy G; Besnard JC
    J Nucl Med; 1980 May; 21(5):466-70. PubMed ID: 6246225
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stabilization of 99mTc-pyrophosphate injection with gentisic acid.
    Ballinger J; Der M; Bowen B
    Eur J Nucl Med; 1981 Apr; 6(4):153-4. PubMed ID: 6260499
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Letter: Toxicity of HEDP in humans.
    Citrin DL
    J Nucl Med; 1976 May; 17(5):417-8. PubMed ID: 1262951
    [No Abstract]   [Full Text] [Related]  

  • 28. Significance of femur and liver radioactivity in relation to quality and fate of phosphate complexes labeled with technetium-99m.
    Hosain P; Hosain F
    Nuklearmedizin; 1976 Apr; 15(2):95-6. PubMed ID: 179062
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical comparison of the kinetics of 99mTc pyrophosphate and 99mTc methylene diphosphonate (author's transl)].
    Casara D; Cimitan M; Zorat P; Calzavara F
    Radiol Med; 1979; 65(1-2):67-70. PubMed ID: 223200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of the bone seeking properties of short-chained 99mTc-Sn-polyphosphates.
    Schümichen C; Nakken KF
    Nucl Med (Stuttg); 1974 Aug; 13(2):139-43. PubMed ID: 4373697
    [No Abstract]   [Full Text] [Related]  

  • 31. Technetium-99m-Sn-pyrophosphate pharmaco-kinetics and bone image changes in parathyroid disease.
    Krishnamurthy GT; Brickman AS; Blahd WH
    J Nucl Med; 1977 Mar; 18(3):236-42. PubMed ID: 190364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmaco-kinetics of current skeletal-seeking radiopharmaceuticals.
    Krishnamurthy GT; Huebotter RJ; Tubis M; Blahd WH
    AJR Am J Roentgenol; 1976 Feb; 126(2):293-301. PubMed ID: 175699
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preparation and biological distribution of technetium diphosphonate radiotracers synthesized without stannous ion.
    Deutsch E; Libson K; Becker CB; Francis MD; Tofe AJ; Ferguson DL; McCreary LD
    J Nucl Med; 1980 Sep; 21(9):859-66. PubMed ID: 6774066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of 99mTc complexes for renal imaging.
    Arnold RW; Subramanian G; McAfee JG; Blair RJ; Thomas FD
    J Nucl Med; 1975 May; 16(5):357-67. PubMed ID: 1194986
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Investigations on the bone uptake of 99mTc-pyrophosphate, 99mTc-poly-phosphate and radio-strontium (author's transl)].
    Büll U; Frey KW
    Fortschr Geb Rontgenstr Nuklearmed; 1973 Nov; 119(5):569-77. PubMed ID: 4360989
    [No Abstract]   [Full Text] [Related]  

  • 36. Technetium-99m labeled agents for skeletal imaging.
    Thrall JH
    CRC Crit Rev Clin Radiol Nucl Med; 1976; 8(1):1-31. PubMed ID: 789010
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Sodium pyrophosphate labeled by technetium 99m in the study of bone metastases. Role and limitations of the examination].
    Ducassou D; Pigneux J; Leccia F; Brendel A
    J Radiol Electrol Med Nucl; 1975; 56 suppl 2():562-3. PubMed ID: 182998
    [No Abstract]   [Full Text] [Related]  

  • 38. Localization of skeletal-imaging 99mTc chelates in dead cells in tissue culture: concise communication.
    Dewanjee MK
    J Nucl Med; 1976 Nov; 17(11):993-7. PubMed ID: 978263
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Incorporation of radioactive calcium and technetium pyrophosphate in to bones].
    Markt B; Bergmann G; Raab W; Willvonseder R
    Acta Med Austriaca; 1977; 4(4-9):144-8. PubMed ID: 205073
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investigation of the parameters related to the formation of 99mTc-pyrophosphate complexes using gel chromatography column scanning.
    Shafiq YF; Al-Janabi MA; Al-Azzawi HM; Abdel-Azeez MA; Al-Hissoni MH; Jassim MN
    Nuklearmedizin; 1985 Jun; 24(3):146-9. PubMed ID: 2997754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.